Keep up with the latest moves made in health policy under President Donald Trump's second administration. This timeline will ...
Virax Biolabs Group Limited (NASDAQ:VRAX) said it supports the U.S. Department of Health and Human Services’ focus on vaccine efficacy transparency, emphasizing the need for accessible information to ...
Kennedy’s first week at HHS included dismissing the workforce, vaccine advisers and some longtime health priorities.
To read this article for FREE, please sign in to your account or sign up for a free account.
Dynavax reports record HEPLISAV-B revenue, 26% growth in 2024, and strong 2025 guidance. Insights on shingles vaccine progress & market expansion.
“The comment that [Kennedy] made about the vaccine schedule, it’s basically scientific racism, which has been debunked,” Dr.
Dynavax Technologies Corporation ( NASDAQ: DVAX) Q4 2024 Earnings Conference Call February 20, 2025 4:30 PM ET Paul Cox - Vice President, Investor Relations & Corporate Communications Ryan Spencer - ...
Portuguese biotechnology company Immunethep is receiving $2 million from CARB-X to develop a conjugate peptide-based vaccine ...
ACIP holds full-committee public meetings at least three times a year to review evidence on vaccines and vote on new ...
Seventy-one years ago this month, Dr. Jonas Salk, a virologist at the University of Pittsburgh, administered the first polio vaccine to children at Arsenal Elementary School in Pittsburgh. Dr. Salk ...
The first month of the Trump administration has brought chaos to US health agencies through mass firings, funding ...